Fiona Kellas#2427

Dr. Fiona Kellas

Fiona graduated from the University of Glasgow with an Honours degree in Biochemistry and was subsequently awarded a PhD in Biochemistry from the University of Cambridge. During her PhD, Fiona carried out research in the MRC LMB (MRC Laboratory of Molecular Biology) and in the MRC Mitochondrial Biology Unit in Cambridge. During her research Fiona carried out structural studies on the ATP synthase enzyme in the laboratory of Professor Sir John Walker.

Fiona is a qualified UK and European Patent Attorney. In addition to working in private practice, Fiona has experience of working in-house in the intellectual property department of an antibody technology company. Fiona has experience of drafting and prosecuting patent applications, preparing and filing design applications, as well as prior art and freedom to operate searching and assessment. Fiona has worked in a wide range of technologies. In particular, she has experience in the areas of biochemistry, antibody technology, industrial biotechnology, in vitro diagnostics, digital health and medical technologies and devices.
Contributed to

2

Intellectual property protection for digital health
Intellectual property protection for digital health
Practice notes

This Practice Note discusses the various intellectual property (IP) rights that can be used to protect a digital health product. It also addresses other IP considerations, such as protection as a trade secret, the use of open source software, potential ownership disputes with employees and contractors, IP licences, and the protection of patient data. The Practice Note also considers IP strategy during digital health product development, from conception and initial research to advertising, marketing and sale and future developments and improvements.

Intellectual property protection for medical devices
Intellectual property protection for medical devices
Practice notes

This Practice Note discusses the intellectual property (IP) rights which are of key importance during each stage of the life cycle of a medical device, ie during conception, research, development, design, advertising, marketing, sale, and future developments and improvements. This Practice Note also discusses the relevance and importance of confidentiality, non-disclosure agreements, IP ownership, and freedom to operate searches.

Practice Area

Panel

  • Contributing Author

Membership

  • CIPA

Education

  • University of Glasgow with an Honours degree in Biochemistry in 1998
  • PhD in Biochemistry from the University of Cambridge in 2003

If you expected to see yourself on this page, click here.